Back to top

Repligen Stock (RGEN) Rises After Investors Wowed By ‘Market Leading’ Q2 Figures

Shares in Biopharma manufacturing company Repligen Corporation ($RGEN) raced 3% higher in early trading today after blockbuster results and a top a...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Repligen Corporation (RGEN)